RETA $166 +53%
They have 420 million cash on hand and 180 million in debt, my personal belief is if no offering tomorrow pre market and by the looks of it nothing has been filed recently for anything related to shelf offering, if nothing by open, this could hit 120 tomorrow. Lots of puts out there, people are betting against the company for some reason, they think this company is going to throw an offering. We will see how it plays out tomorrow. I am bullish and I think this will top out between 120-130, now if they bring in Baker Brothers like MD*GL did, then I think it might even hit 175 dollars fade off from there. Goldman Sachs price target after the press release 185.00 dollars, Citigroup price target $120.00
probably not because we arent in
dino is do it will go to $110+
It got down low last week when the FDA head of neuroscience resigned.
I followed RETA a lot when they moved over 200 per share. Good company. Never should have been 30 a share.
Goldman Sachs have a price target of $170 today. Incredible.
Wild. I was gonna buy some calls after seeing this but never did. Would have made bank. Congrats.
Thanks. The company will have trouble growing this medicine line however.
Shorts hurt'n for cert'n, though prolly from 45ish than 30.
I suspect a sell-down as only a 5,000 US patient base.
May put some sink orders in..
Good morning G2, Ske, DG and all!
Let's make it happen again, today!
CONGRAT$ 75-90 THIS MORN
ANY SHORT MUST BE GOING CRAZY
Yes if they were short.
RETA My story. What's yours?
RETA Thank you for the news, G2G! I was in and won bigly! Hope you did, too.
Good evening, G2G, DG, Ske and all. What a day!
My sister, who is a saint, but more intense than police working you in the small, cement interrogation room for a possible double murder, called late last night and got me all riled up. So this morning my head was spinning like a top.
But I seemed to have ploughed through the day successfully, as follows:
I started at 9:35 AM and traded until about 1PM, a little late for me. One of the things I did was lay in 40% of the position size in RETA that I day traded yesterday.
I only took a small amount because I'm playing for average this year. Not swinging for the fence at all. But I felt a small position was remediable if I whiffed.
I somehow made two afternoon deliveries in the rugged mountains of West Virginia and a cold call (prospecting). I was going like I did when I was a twenty something food salesman on the road. Now I'm approaching a septuagenarian food salesman on the road :)
Tossing the crates of honey back on the truck after my second delivery, I jumped in the cab and punched up Fidelity to see if RETA passed FDA. Well, wifi positively sucks lemons in the WV mountains! But I did see RETA was halted so I still had time to act- if I could find decent wifi. I ended up in a Taco Bell with pretty horrible wifi itself. Bid-Ask resumed at 5:50 PM and trading at 5:55. After watching the circle of doom too long, I finally got on at 5.54:55! I couldn't fick around with such a poor wifi connection so I went right out of my position.
Yesterday's RETA DayTrade: In @ 30, out @ 31.45 for a 4.83% win
Today's RETA Day Trade: In @ 30.05, out at 82.88 (It passed!) for a 176% win!
I did all this with a broken tooth/exposed nerve and no pain killer.
My account is up approximately 35% YTD, which extrapolates to approximately 217% per annum.
41 closed positions: 39 green, 2 red
15 open positions: 9 red, 6 green
Good night folks. Got to go find my lodging tonight.
Tomorrow we do it again!
I heard. That should have no direct effect on approval though.
Apparently it is because they were expecting FDA approval tomorrow and the head of FDA agency just resigned.
What am I missing?????
Alport syndrome is estimated to affect approximately 1 in 5,000-10,000 people in the general population in the United States, which means that approximately 30,000-60,000 people in the United States have the disorder.
Can someone explain something to me. This is 100% of what RETA was being valued at? So let me get this straight. Analysts were valuing this stock all based on this one drug that approximately affects 60K people in the US and valued the company at 250 X 36.4M = 9 billion???? Then the drug doesn't go through and now the value is 1 billion. Please. Someone please for the love of Pete explain that to me.
Ladenburg Thalmann Financial Services is a German Company who posted the $290 target. Way to rich in my opinion; need the revenue stream first. Happy to see it though, I am holding.
Currently $32M in sales, $7.5B Market cap, 230 Price to Sales. It certainly has high hopes the two NDAs will be successful and prompt commercial roll-out possible.
Great future here in my opinion
Phase 3 Cardinal Successful Outcome
Company announces Ph 3 results. Sucessfull endpoints achieved.
Congrats ... you have been in RETA for awhile .
$RETA Reata Pharma (RETA) announces registrational Part 2 portion of MOXIe Phase 2 trial of omaveloxolone in patients with FA met its primary endpoint